Connection

MORVEN EDWARDS to Streptococcal Vaccines

This is a "connection" page, showing publications MORVEN EDWARDS has written about Streptococcal Vaccines.
Connection Strength

1.884
  1. Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination. Vaccine. 2013 Aug 28; 31 Suppl 4:D66-71.
    View in: PubMed
    Score: 0.404
  2. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine. 2012 Jun 13; 30(28):4123-6.
    View in: PubMed
    Score: 0.387
  3. Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum Vaccin. 2008 Nov-Dec; 4(6):444-8.
    View in: PubMed
    Score: 0.306
  4. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis. 2003 Jul 01; 188(1):66-73.
    View in: PubMed
    Score: 0.210
  5. A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III. Clin Infect Dis. 2019 05 30; 68(12):2079-2086.
    View in: PubMed
    Score: 0.158
  6. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective? Vaccine. 2014 Aug 20; 32(37):4778-85.
    View in: PubMed
    Score: 0.113
  7. Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation. Vaccine. 2009 Jul 16; 27(33):4452-6.
    View in: PubMed
    Score: 0.079
  8. Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults. Vaccine. 2007 Jan 02; 25(1):55-63.
    View in: PubMed
    Score: 0.065
  9. Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old. J Infect Dis. 2004 Aug 01; 190(3):558-64.
    View in: PubMed
    Score: 0.056
  10. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis. 2004 Mar 15; 189(6):1103-12.
    View in: PubMed
    Score: 0.055
  11. Serocorrelates of protection against infant group B streptococcus disease. Lancet Infect Dis. 2019 05; 19(5):e162-e171.
    View in: PubMed
    Score: 0.039
  12. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun. 2002 Apr; 70(4):1724-38.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.